Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 31 entries
Sorted by: Best Match Show Resources per page
Immune response to racotumomab in a child with relapsed neuroblastoma.

Frontiers in oncology

Sampor C, Guthmann MD, Scursoni A, Cacciavillano W, Torbidoni A, Galluzzo L, Camarero S, Lopez J, de Dávila MT, Fainboim L, Chantada GL.
PMID: 23267436
Front Oncol. 2012 Dec 20;2:195. doi: 10.3389/fonc.2012.00195. eCollection 2012.

Immunotherapy targeting ganglioside antigens is a powerful tool for the treatment of high risk neuroblastoma. However, only treatment with anti-GD2 antibodies has been used in clinical practice and other options may be pursued. We report the use of racotumomab,...

Cite
Sampor C, Guthmann MD, Scursoni A, et al. Immune response to racotumomab in a child with relapsed neuroblastoma. Front Oncol. 2012;2:195doi: 10.3389/fonc.2012.00195.
Sampor, C., Guthmann, M. D., Scursoni, A., Cacciavillano, W., Torbidoni, A., Galluzzo, L., Camarero, S., Lopez, J., de Dávila, M. T., Fainboim, L., & Chantada, G. L. (2012). Immune response to racotumomab in a child with relapsed neuroblastoma. Frontiers in oncology, 2195. https://doi.org/10.3389/fonc.2012.00195
Sampor, C, et al. "Immune response to racotumomab in a child with relapsed neuroblastoma." Frontiers in oncology vol. 2 (2012): 195. doi: https://doi.org/10.3389/fonc.2012.00195
Sampor C, Guthmann MD, Scursoni A, Cacciavillano W, Torbidoni A, Galluzzo L, Camarero S, Lopez J, de Dávila MT, Fainboim L, Chantada GL. Immune response to racotumomab in a child with relapsed neuroblastoma. Front Oncol. 2012 Dec 20;2:195. doi: 10.3389/fonc.2012.00195. eCollection 2012. PMID: 23267436; PMCID: PMC3526767.
Copy Download .nbib Format: NLM
Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz .

Journal for immunotherapy of cancer

Mora J, Chantada GL.
PMID: 34893525
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003751.

No abstract available.

Cite
Mora J, Chantada GL. Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz . J Immunother Cancer. 2021;9(12)doi: 10.1136/jitc-2021-003751.
Mora, J., & Chantada, G. L. (2021). Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz . Journal for immunotherapy of cancer, 9(12), . https://doi.org/10.1136/jitc-2021-003751
Mora, Jaume, and Chantada, Guillermo L. "Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz ." Journal for immunotherapy of cancer vol. 9,12 (2021). doi: https://doi.org/10.1136/jitc-2021-003751
Mora J, Chantada GL. Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz . J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003751. PMID: 34893525.
Copy Download .nbib Format: NLM
The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA.

Ecancermedicalscience

Pritchard-Jones K, de C V Abib S, Esiashvili N, Kaspers GJL, Rosser J, Van Doorninck JA, Braganca JML, Hoffman RI, Rodriguez-Galindo C, Adams C, Connor SR, Abdelhafeez AH, Bouffet E, Howard SC, Challinor JM, Hessissen L, Dalvi RB, Kearns P, Chantada GL, Frazier LA, Sullivan MJ, Schulte FSM, Morrissey LK, Kozhaeva O, Luna-Fineman S, Khan MS.
PMID: 33777180
Ecancermedicalscience. 2021 Feb 15;15:1187. doi: 10.3332/ecancer.2021.1187. eCollection 2021.

The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the globe. While the pandemic has had a profound impact on access to and delivery of health care by all services, it has been particularly disruptive...

Cite
Pritchard-Jones K, de C V Abib S, Esiashvili N, et al. The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA. Ecancermedicalscience. 2021;15:1187doi: 10.3332/ecancer.2021.1187.
Pritchard-Jones, K., de C V Abib, S., Esiashvili, N., Kaspers, G. J. L., Rosser, J., Van Doorninck, J. A., Braganca, J. M. L., Hoffman, R. I., Rodriguez-Galindo, C., Adams, C., Connor, S. R., Abdelhafeez, A. H., Bouffet, E., Howard, S. C., Challinor, J. M., Hessissen, L., Dalvi, R. B., Kearns, P., Chantada, G. L., Frazier, L. A., Sullivan, M. J., Schulte, F. S. M., Morrissey, L. K., Kozhaeva, O., Luna-Fineman, S., & Khan, M. S. (2021). The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA. Ecancermedicalscience, 151187. https://doi.org/10.3332/ecancer.2021.1187
Pritchard-Jones, Kathy, et al. "The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA." Ecancermedicalscience vol. 15 (2021): 1187. doi: https://doi.org/10.3332/ecancer.2021.1187
Pritchard-Jones K, de C V Abib S, Esiashvili N, Kaspers GJL, Rosser J, Van Doorninck JA, Braganca JML, Hoffman RI, Rodriguez-Galindo C, Adams C, Connor SR, Abdelhafeez AH, Bouffet E, Howard SC, Challinor JM, Hessissen L, Dalvi RB, Kearns P, Chantada GL, Frazier LA, Sullivan MJ, Schulte FSM, Morrissey LK, Kozhaeva O, Luna-Fineman S, Khan MS. The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA. Ecancermedicalscience. 2021 Feb 15;15:1187. doi: 10.3332/ecancer.2021.1187. eCollection 2021. PMID: 33777180; PMCID: PMC7987488.
Copy Download .nbib Format: NLM
Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma.

Molecular medicine reports

Laurent VE, Otero LL, Vazquez V, Camarero S, Gabri MR, Labraga M, De Dávila MT, Chantada GL, Alonso DF.
PMID: 21472230
Mol Med Rep. 2010 Mar-Apr;3(2):253-9. doi: 10.3892/mmr_00000248.

Extraocular dissemination is the main cause of death in patients with retinoblastoma (RB) in developing countries, and there are few molecular markers that are useful for the evaluation of minimal disseminated disease. The GD2 ganglioside is known to be...

Cite
Laurent VE, Otero LL, Vazquez V, et al. Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma. Mol Med Rep. 2010;3(2):253-9doi: 10.3892/mmr_00000248.
Laurent, V. E., Otero, L. L., Vazquez, V., Camarero, S., Gabri, M. R., Labraga, M., De Dávila, M. T., Chantada, G. L., & Alonso, D. F. (2010). Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma. Molecular medicine reports, 3(2), 253-9. https://doi.org/10.3892/mmr_00000248
Laurent, Viviana E, et al. "Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma." Molecular medicine reports vol. 3,2 (2010): 253-9. doi: https://doi.org/10.3892/mmr_00000248
Laurent VE, Otero LL, Vazquez V, Camarero S, Gabri MR, Labraga M, De Dávila MT, Chantada GL, Alonso DF. Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma. Mol Med Rep. 2010 Mar-Apr;3(2):253-9. doi: 10.3892/mmr_00000248. PMID: 21472230.
Copy Download .nbib Format: NLM
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.

Ecancermedicalscience

Rosé A, André N, Rozados VR, Mainetti LE, Menacho Márquez M, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Graupera JM, García WG, Epelman S, Alasino C, Alonso D, Chantada G, Scharovsky OG.
PMID: 27610198
Ecancermedicalscience. 2016 Sep 06;10:672. doi: 10.3332/ecancer.2016.672. eCollection 2016.

Following previous metronomic meetings in Marseille (2011), Milano (2014), and Mumbai (2016), the first Latin American metronomic meeting was held in the School of Medical Sciences, National University of Rosario, Rosario, Argentina on 27 and 28 of May, 2016....

Cite
Rosé A, André N, Rozados VR, et al. Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina. Ecancermedicalscience. 2016;10:672doi: 10.3332/ecancer.2016.672.
Rosé, A., André, N., Rozados, V. R., Mainetti, L. E., Menacho Márquez, M., Rico, M. J., Schaiquevich, P., Villarroel, M., Gregianin, L., Graupera, J. M., García, W. G., Epelman, S., Alasino, C., Alonso, D., Chantada, G., & Scharovsky, O. G. (2016). Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina. Ecancermedicalscience, 10672. https://doi.org/10.3332/ecancer.2016.672
Rosé, Adriana, et al. "Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina." Ecancermedicalscience vol. 10 (2016): 672. doi: https://doi.org/10.3332/ecancer.2016.672
Rosé A, André N, Rozados VR, Mainetti LE, Menacho Márquez M, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Graupera JM, García WG, Epelman S, Alasino C, Alonso D, Chantada G, Scharovsky OG. Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina. Ecancermedicalscience. 2016 Sep 06;10:672. doi: 10.3332/ecancer.2016.672. eCollection 2016. PMID: 27610198; PMCID: PMC5014555.
Copy Download .nbib Format: NLM
COVID-19: Consequences for Children With Cancer in Turkey and Globally.

Turkish archives of pediatrics

Kebudi R, Chantada G, Kurucu N, Tuğcu D, Mukkada S, C Moreira D.
PMID: 35005722
Turk Arch Pediatr. 2021 Jul 01;56(4):295-299. doi: 10.5152/TurkArchPediatr.2021.21134. eCollection 2021 Jul.

No abstract available.

Cite
Kebudi R, Chantada G, Kurucu N, et al. COVID-19: Consequences for Children With Cancer in Turkey and Globally. Turk Arch Pediatr. 2021;56(4):295-299doi: 10.5152/TurkArchPediatr.2021.21134.
Kebudi, R., Chantada, G., Kurucu, N., Tuğcu, D., Mukkada, S., & C Moreira, D. (2021). COVID-19: Consequences for Children With Cancer in Turkey and Globally. Turkish archives of pediatrics, 56(4), 295-299. https://doi.org/10.5152/TurkArchPediatr.2021.21134
Kebudi, Rejin, et al. "COVID-19: Consequences for Children With Cancer in Turkey and Globally." Turkish archives of pediatrics vol. 56,4 (2021): 295-299. doi: https://doi.org/10.5152/TurkArchPediatr.2021.21134
Kebudi R, Chantada G, Kurucu N, Tuğcu D, Mukkada S, C Moreira D. COVID-19: Consequences for Children With Cancer in Turkey and Globally. Turk Arch Pediatr. 2021 Jul 01;56(4):295-299. doi: 10.5152/TurkArchPediatr.2021.21134. eCollection 2021 Jul. PMID: 35005722; PMCID: PMC8655955.
Copy Download .nbib Format: NLM
High prevalence of BRAF.

Pediatric blood & cancer

Carrere X, Pinto N, Gene Olaciregui N, Galluzzo L, Rossetti E, Celis Passini V, Salvador Marcos N, Chantada G, Braier J, Lavarino C, Felizzia G.
PMID: 33991404
Pediatr Blood Cancer. 2021 Jul;68(7):e29115. doi: 10.1002/pbc.29115. Epub 2021 May 15.

Targeted therapies with MAPK inhibitors have proven to modulate the clinical manifestations of patients with Langerhans cell histiocytosis (LCH). We explored the presence of BRAF

Cite
Carrere X, Pinto N, Gene Olaciregui N, et al. High prevalence of BRAF. Pediatr Blood Cancer. 2021;68(7):e29115doi: 10.1002/pbc.29115.
Carrere, X., Pinto, N., Gene Olaciregui, N., Galluzzo, L., Rossetti, E., Celis Passini, V., Salvador Marcos, N., Chantada, G., Braier, J., Lavarino, C., & Felizzia, G. (2021). High prevalence of BRAF. Pediatric blood & cancer, 68(7), e29115. https://doi.org/10.1002/pbc.29115
Carrere, Xiomara, et al. "High prevalence of BRAF." Pediatric blood & cancer vol. 68,7 (2021): e29115. doi: https://doi.org/10.1002/pbc.29115
Carrere X, Pinto N, Gene Olaciregui N, Galluzzo L, Rossetti E, Celis Passini V, Salvador Marcos N, Chantada G, Braier J, Lavarino C, Felizzia G. High prevalence of BRAF. Pediatr Blood Cancer. 2021 Jul;68(7):e29115. doi: 10.1002/pbc.29115. Epub 2021 May 15. PMID: 33991404.
Copy Download .nbib Format: NLM
Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study.

The Lancet. Child & adolescent health

Graetz D, Agulnik A, Ranadive R, Vedaraju Y, Chen Y, Chantada G, Metzger ML, Mukkada S, Force LM, Friedrich P, Lam C, Sniderman E, Bhakta N, Hessissen L, Dalvi R, Devidas M, Pritchard-Jones K, Rodriguez-Galindo C, Moreira DC.
PMID: 33675698
Lancet Child Adolesc Health. 2021 May;5(5):332-340. doi: 10.1016/S2352-4642(21)00031-6. Epub 2021 Mar 04.

BACKGROUND: Although mortality due to COVID-19 has been reportedly low among children with cancer, changes in health-care services due to the pandemic have affected cancer care delivery. This study aimed to assess the effect of the COVID-19 pandemic on...

Cite
Graetz D, Agulnik A, Ranadive R, et al. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. Lancet Child Adolesc Health. 2021;5(5):332-340doi: 10.1016/S2352-4642(21)00031-6.
Graetz, D., Agulnik, A., Ranadive, R., Vedaraju, Y., Chen, Y., Chantada, G., Metzger, M. L., Mukkada, S., Force, L. M., Friedrich, P., Lam, C., Sniderman, E., Bhakta, N., Hessissen, L., Dalvi, R., Devidas, M., Pritchard-Jones, K., Rodriguez-Galindo, C., & Moreira, D. C. (2021). Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. The Lancet. Child & adolescent health, 5(5), 332-340. https://doi.org/10.1016/S2352-4642(21)00031-6
Graetz, Dylan, et al. "Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study." The Lancet. Child & adolescent health vol. 5,5 (2021): 332-340. doi: https://doi.org/10.1016/S2352-4642(21)00031-6
Graetz D, Agulnik A, Ranadive R, Vedaraju Y, Chen Y, Chantada G, Metzger ML, Mukkada S, Force LM, Friedrich P, Lam C, Sniderman E, Bhakta N, Hessissen L, Dalvi R, Devidas M, Pritchard-Jones K, Rodriguez-Galindo C, Moreira DC. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. Lancet Child Adolesc Health. 2021 May;5(5):332-340. doi: 10.1016/S2352-4642(21)00031-6. Epub 2021 Mar 04. PMID: 33675698; PMCID: PMC7929816.
Copy Download .nbib Format: NLM
Temporal zone plate.

Journal of the Optical Society of America. A, Optics, image science, and vision

Flores-Arias MT, Chantada L, Bao C, Pérez MV, Gómez-Reino C.
PMID: 19037399
J Opt Soc Am A Opt Image Sci Vis. 2008 Dec;25(12):3077-82. doi: 10.1364/josaa.25.003077.

This paper extends the investigation of zone plates to the temporal case. By exploiting the space-time duality between the paraxial diffraction of beams in space and the linear dispersion of optical pulses, we present the time-domain analog of a...

Cite
Flores-Arias MT, Chantada L, Bao C, et al. Temporal zone plate. J Opt Soc Am A Opt Image Sci Vis. 2008;25(12):3077-82doi: 10.1364/josaa.25.003077.
Flores-Arias, M. T., Chantada, L., Bao, C., Pérez, M. V., & Gómez-Reino, C. (2008). Temporal zone plate. Journal of the Optical Society of America. A, Optics, image science, and vision, 25(12), 3077-82. https://doi.org/10.1364/josaa.25.003077
Flores-Arias, Maria Teresa, et al. "Temporal zone plate." Journal of the Optical Society of America. A, Optics, image science, and vision vol. 25,12 (2008): 3077-82. doi: https://doi.org/10.1364/josaa.25.003077
Flores-Arias MT, Chantada L, Bao C, Pérez MV, Gómez-Reino C. Temporal zone plate. J Opt Soc Am A Opt Image Sci Vis. 2008 Dec;25(12):3077-82. doi: 10.1364/josaa.25.003077. PMID: 19037399.
Copy Download .nbib Format: NLM
A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding.

Journal of clinical and diagnostic research : JCDR

Ravibabu K, Palla J, Chintada GS.
PMID: 24392393
J Clin Diagn Res. 2013 Nov;7(11):2534-6. doi: 10.7860/JCDR/2013/6396.3602. Epub 2013 Nov 10.

OBJECTIVE: This study was carried out to evaluate the efficacy of Ormeloxifene in the pharmacological management of dysfunctional uterine bleeding.DESIGN AND SETTING: A prospective study was conducted on women with dysfunctional uterine bleeding, who attended to out - patient...

Cite
Ravibabu K, Palla J, Chintada GS. A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding. J Clin Diagn Res. 2013;7(11):2534-6doi: 10.7860/JCDR/2013/6396.3602.
Ravibabu, K., Palla, J., & Chintada, G. S. (2013). A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding. Journal of clinical and diagnostic research : JCDR, 7(11), 2534-6. https://doi.org/10.7860/JCDR/2013/6396.3602
Ravibabu, Komaram, et al. "A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding." Journal of clinical and diagnostic research : JCDR vol. 7,11 (2013): 2534-6. doi: https://doi.org/10.7860/JCDR/2013/6396.3602
Ravibabu K, Palla J, Chintada GS. A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding. J Clin Diagn Res. 2013 Nov;7(11):2534-6. doi: 10.7860/JCDR/2013/6396.3602. Epub 2013 Nov 10. PMID: 24392393; PMCID: PMC3879867.
Copy Download .nbib Format: NLM
Use of intra-arterial chemotherapy for retinoblastoma: results of a survey.

International journal of ophthalmology

Grigorovski N, Lucena E, Mattosinho C, Parareda A, Ferman S, Catalá J, Chantada G.
PMID: 25161951
Int J Ophthalmol. 2014 Aug 18;7(4):726-30. doi: 10.3980/j.issn.2222-3959.2014.04.26. eCollection 2014.

AIM: To obtain baseline knowledge about the current use of intra-arterial chemotherapy (SSOAIC) in centers worldwide.METHODS: A survey including questions about the use of SSOAIC was emailed to retinoblastoma experts.RESULTS: Seventy-nine (response rate 69.9%) doctors from 63 centers in...

Cite
Grigorovski N, Lucena E, Mattosinho C, et al. Use of intra-arterial chemotherapy for retinoblastoma: results of a survey. Int J Ophthalmol. 2014;7(4):726-30doi: 10.3980/j.issn.2222-3959.2014.04.26.
Grigorovski, N., Lucena, E., Mattosinho, C., Parareda, A., Ferman, S., Catalá, J., & Chantada, G. (2014). Use of intra-arterial chemotherapy for retinoblastoma: results of a survey. International journal of ophthalmology, 7(4), 726-30. https://doi.org/10.3980/j.issn.2222-3959.2014.04.26
Grigorovski, Nathalia, et al. "Use of intra-arterial chemotherapy for retinoblastoma: results of a survey." International journal of ophthalmology vol. 7,4 (2014): 726-30. doi: https://doi.org/10.3980/j.issn.2222-3959.2014.04.26
Grigorovski N, Lucena E, Mattosinho C, Parareda A, Ferman S, Catalá J, Chantada G. Use of intra-arterial chemotherapy for retinoblastoma: results of a survey. Int J Ophthalmol. 2014 Aug 18;7(4):726-30. doi: 10.3980/j.issn.2222-3959.2014.04.26. eCollection 2014. PMID: 25161951; PMCID: PMC4137215.
Copy Download .nbib Format: NLM
Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs.

Journal of global oncology

Chantada GL, Dunkel IJ, Schaiquevich PS, Grynszpancholc EL, Francis J, Ceciliano A, Zubizarreta PA, Fandiño AC, Abramson DH.
PMID: 28717719
J Glob Oncol. 2016 Mar 30;2(6):347-352. doi: 10.1200/JGO.2015.002782. eCollection 2016 Dec.

No abstract available.

Cite
Chantada GL, Dunkel IJ, Schaiquevich PS, et al. Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs. J Glob Oncol. 2016;2(6):347-352doi: 10.1200/JGO.2015.002782.
Chantada, G. L., Dunkel, I. J., Schaiquevich, P. S., Grynszpancholc, E. L., Francis, J., Ceciliano, A., Zubizarreta, P. A., Fandiño, A. C., & Abramson, D. H. (2016). Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs. Journal of global oncology, 2(6), 347-352. https://doi.org/10.1200/JGO.2015.002782
Chantada, Guillermo L, et al. "Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs." Journal of global oncology vol. 2,6 (2016): 347-352. doi: https://doi.org/10.1200/JGO.2015.002782
Chantada GL, Dunkel IJ, Schaiquevich PS, Grynszpancholc EL, Francis J, Ceciliano A, Zubizarreta PA, Fandiño AC, Abramson DH. Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs. J Glob Oncol. 2016 Mar 30;2(6):347-352. doi: 10.1200/JGO.2015.002782. eCollection 2016 Dec. PMID: 28717719; PMCID: PMC5493246.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 31 entries